ask="10.55"
ask_size="100"
average_daily_volume="164302"
bid="10.50"
bid_size="300"
book_value="3.69"
change="-0.70"
change_from_200_day_moving_average="0.68"
change_from_50_day_moving_average="-1.23"
change_from_52_week_high="-3.60"
change_From_52_week_low="7.12"
change_in_percent="-5.98%"
close="11.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.98"
ex_dividend_date="N/A"
float_shares="15638000"
high="11.85"
high_52_weeks="14.60"
last_trade_date="1/19/2017"
last_trade_price="11.00"
last_trade_size="2631"
last_trade_time="4:00pm"
low="11.00"
low_52_weeks="3.88"
market_capitalization="196.31M"
moving_average_200_day="10.32"
moving_average_50_day="12.23"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="29.25"
open="11.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+6.59%"
percent_change_from_50_day_moving_average="-10.07%"
percent_change_from_52_week_high="-24.66%"
percent_change_from_52_week_low="+183.51%"
previous_close="11.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.17"
price_per_sales="220.34"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="7.54"
stock_exchange="NCM"
symbol="STML"
volume="137929"
weeks_range_52="3.88 - 14.60"
